Belmont, MA, United States of America

Mariana Nacht

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Kdac Therapeutics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mariana Nacht. Retrieved from https://idiyas.com/inventor/mariana-nacht

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mariana Nacht: Innovator in Cancer Treatment

Introduction

Mariana Nacht is a prominent inventor based in Belmont, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development.

Latest Patents

Mariana Nacht holds a patent for a groundbreaking invention titled "Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer." This patent encompasses compositions, kits, and methods that utilize a selective HDAC3 inhibitor in conjunction with an immunotherapy agent, such as an immune checkpoint inhibitor. Her work aims to enhance the effectiveness of cancer therapies.

Career Highlights

Mariana Nacht is associated with Kdac Therapeutics, Inc., where she continues to advance her research in cancer treatment. Her dedication to innovation in this field has positioned her as a key figure in the development of new therapeutic strategies.

Collaborations

Mariana collaborates with Edward Holson, contributing to the collective efforts in cancer research and treatment advancements.

Conclusion

Mariana Nacht's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. Her contributions are paving the way for more effective therapies that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…